 |
Lonafarnib |
|---|---|
| Trade Name | |
| Orphan Indication | Hepatitis D |
| USA Market Approval | USA |
| USA Designation Date | 2013-11-19 00:00:00 |
| Sponsor | Eiger Biopharmaceuticals, Inc.;PO Box 430;San Carlos, California, 94070 |
| |
Lonafarnib |
|---|---|
| Trade Name | |
| Orphan Indication | Hepatitis D |
| USA Market Approval | USA |
| USA Designation Date | 2013-11-19 00:00:00 |
| Sponsor | Eiger Biopharmaceuticals, Inc.;PO Box 430;San Carlos, California, 94070 |